The new In Vitro Diagnostic Medical Devices Regulation (EU) 2017/746 (IVDR) entered into application on 26 May 2022. The new regulation will...
We are happy to announce that the Norwegian family-owned investment company Ferd will come as a co-owner of Aidian together with Nordstjerna...
Viruses are major causes of upper respiratory tract infections (URTIs). Yet, antibiotics are commonly prescribed for URTIs. Even if, the flu...
We have updated our website with a new sustainability section. You can now find more information about sustainability at Aidian, our commitm...
LabPad and LabPad Evolution systems from Biosynex are now available through Aidian offices in the Czech Republic, Slovakia and Hungary. Lab...
Emerging evidence show that among patients with COVID-19, the risk of death of diabetes is 50% higher than those without diabetes, especiall...
Aidian is a proud distributor of the Meridian's flexible fully automated molecular PCR platform Revogene® that is capable of both single ana...
Non-invasive point of care (POC) faecal immunochemical tests (FITs) aid in triaging both asymptomatic and symptomatic patients for colonosco...